Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2008-04-16. The firm operates in several markets with a variety of pharmaceutical products. The firm's products include: Mantecorp Farmasa, which is an under the umbrella brand; Addera D3, Nesina, Dramin, Alivium, Predsim, Lisador, and Rinosoro, which focus on several medical specialties involving primary care which are present in main therapeutic classes; Mantecorp Skincare, which offer dermo cosmetics recommended by dermatologists and also operates in this segment with the brands Simple Organic, which offers organic, vegan, and cruelty-free products, and Bioage, which focuses on the professional aesthetic treatment market; and Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina, which are over-the-counter medications provided throughout Brazil.
Mr. Breno Toledo De Oliveira 2011 'den beri şirketle birlikte olan Hypera S.A. 'in Chief Executive Officer 'ıdır.
Hypera SA hissesinin fiyat performansı nasıl?
Hypera SA 'in mevcut fiyatı $4.86 'dir, son işlem günde 0% azalmış etti.
Hypera S.A. için ana iş temaları veya sektörler nelerdir?
Hypera S.A. Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Hypera S.A. 'in piyasa değerlemesi nedir?
Hypera S.A. 'in mevcut piyasa değerlemesi $3.4B 'dir
Hypera S.A. al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 14 analist Hypera S.A. için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 9 al, 7 tut, 0 sat ve 4 güçlü sat içermektedir